All In Biotech

Drug Trial Radar · NCT07189208

Evaluation of Antimicrobial Prophylaxis to Prevent Syphilis in Pregnancy in Patients at Risk in Rio de Janeiro, Brazil

Last checked: Nov 20, 2026Latest source record: Jun 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 500 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Sep 24, 2025

Primary completion

Dec 1, 2029

Study completion Jul 31, 2030

Sponsor

Lead sponsor
University of California, Los AngelesAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
First posted
Sep 23, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
Female only, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if benzathine penicillin works to prevent maternal syphilis. It will also learn about the safety of benzathine penicillin. The main questions it aims to answer are: * Does benzathine penicillin lower the rate of syphilis in pregnancy? * What medical problems do participants have when taking benzathine penicillin? Researchers will compare benzathine penicillin to routine care to see if benzathine penicillin works to prevent syphilis. Participants will: * Take benzathine penicillin or receive routine care during the third trimester of pregnancy * Visit the clinic once a month for injections and tests * Report any reactions to benzathine penicillin to the study team

Conditions

  • Congenital Syphilis

Interventions

  • Benzathine penicillin 2.4 million unitsDrug

    IM injection of BPG

  • Counseling and intensified testing.Behavioral

    Brazilian Ministry of Health guidelines for the prevention and diagnosis of maternal syphilis consist of counseling about STI prevention and syphilis testing at the first pre-natal consultation, at a subsequent consultation during or after 28 weeks of pregnancy, at delivery, and in case of abortion or stillbirth. In this study, intensified testing refers to treponemal and non-treponemal tests once every four weeks beginning as of the 28th week of pregnancy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with absence of maternal syphilis infectionTime frame: Labor and delivery

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Centro de Referencia e Atenção Especializada a Saúde da Mulher (CRAESM)

    Duque de Caxias, Rio de Janeiro, Brazil · Not yet recruiting

  • Policlínica Hospital Municipal Duque de Caxias

    Duque de Caxias, Rio de Janeiro, Brazil · Recruiting

  • Unidade Básica de Saúde José de Freitas

    Duque de Caxias, Rio de Janeiro, Brazil · Not yet recruiting

  • Hospital Federal dos Servidores do Estado

    Rio de Janeiro, Rio de Janeiro, Brazil · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.